Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice

Biochemical Pharmacology

Volumn 58, Issue 2, 1999, Pages 375-382

  Gorman, Nadia ^a   Walton, Heidi S ^a   Bement, William J ^b   Honsinger, Charles P ^a   Szakacs, Juliana G ^c   Sinclair, Jacqueline F ^a,b,c   Sinclair, Peter R ^a,b,c  

^a VA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

C57BL 6; CYP; Iron; SWR; Uroporphyrin; Uroporphyrin accumulation caused by iron and 5 aminolevulinate

Indexed keywords

ALCOHOL; AMINOLEVULINIC ACID; IRON; PHENACETIN O DEETHYLASE; PROTOPORPHYRIN; UROPORPHYRIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; PORPHYRIA; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; ANIMALS; CYTOCHROME P-450 CYP1A2; IMMUNOHISTOCHEMISTRY; IRON; LIVER; MICE; MICE, INBRED C57BL; SPECIES SPECIFICITY; UROPORPHYRINS;

EID: 0033566343     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00088-X     Document Type: Article

References (39)

1. Anderson KE, The porphyrias. In: Hepatology (Eds. Zakim D and Boyer TD), 3rd Edn, pp. 417-463. W. B. Saunders, Philadelphia, 1996.
2. Elder G.H. Porphyria cutanea tarda A multifactorial disease . Campion R.H., Pye R.J. Recent Advances in Dermatology. Vol. 8:1990;55-69 Churchill Livingstone, Edinburgh.
3. Elder G.H. Porphyria cutanea tarda. Semin Liver Dis. 18:1998;67-75.
4. Schmid R. Cutaneous porphyria in Turkey. N Engl J Med. 263:1960;397-398.
5. Goldstein J.A., Hickman P., Bergman H., Vos J.G. Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse. Res Commun Chem Pathol Pharmacol. 6:1973;919-928.
6. Whitlock J.P. Jr. Mechanistic aspects of dioxin action. Chem Res Toxicol. 6:1993;754-763.
7. Sinclair P.R., Granick S. Uroporphyrin formation induced by chlorinated hydrocarbons (lindane, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin). Requirements for endogenous iron, protein synthesis and drug-metabolizing activity. Biochem Biophys Res Commun. 61:1974;124-134.
8. Sinclair P.R., Bement W.J., Bonkovsky H.L., Sinclair J.F. Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Biochem J. 222:1984;737-748.
9. Sinclair P.R., Bement W.J., Bonkovsky H.L., Lambrecht R.W., Frezza J.E., Sinclair J.F., Urquhart A.J., Elder G.H. Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Biochem J. 237:1986;63-71.
10. Sinclair P.R., Bement W.J., Lambrecht R.W., Gorman N., Sinclair J.F. Chlorinated biphenyls induce cytochrome P4501A2 and uroporphyrin accumulation in cultures of mouse hepatocytes. Arch Biochem Biophys. 281:1990;225-232.
11. Madra S., Smith A.G. Induction of cytochrome P450 activities by polychlorinated biphenyls in isolated mouse hepatocytes. Biochem Pharmacol. 44:1992;455-464.
12. Lambrecht R.W., Sinclair P.R., Gorman N., Sinclair J.F. Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P4501A2. Arch Biochem Biophys. 294:1992;504-510.
13. Sinclair P.R., Gorman N., Dalton T., Walton H.S., Bement W.J., Sinclair J.F., Smith A.G., Nebert D.W. Uroporphyria produced in mice by iron and 5-aminolevulinic acid does not occur in Cyp1a2(-/-) null mutant mice. Biochem J. 330:1998;149-153.
14. Roberts A.G., Whatley S.D., Morgan R.R., Worwood M., Elder G.H. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 349:1997;321-323.
15. Greig J.B., Francis J.E., Kay S.J.E., Lovell D.P., Smith A.G. Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice. Toxicol Appl Pharmacol. 74:1984;17-25.
16. Hahn M.E., Gasiewicz T.A., Linko P., Goldstein J.A. The role of the Ah locus in hexachlorobenzene-induced porphyria Studies in congenic C57BL/6J mice . Biochem J. 254:1988;245-254.
17. Akhtar R.A., Smith A.G. Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism. Pharmacogenetics. 8:1998;485-494.
18. Sinclair P.R., Gorman N., Shedlofsky S.I., Honsinger C.P., Sinclair J.F., Karagas M.R., Anderson K.E. Ascorbic acid deficiency in porphyria cutanea tarda. J Lab Clin Med. 130:1997;197-201.
19. Deam S., Elder G.H. Uroporphyria produced in mice by iron and 5-aminolevulinic acid Biochem Pharmacol. 41:1991;2019-2022.
20. Smith A.G., Francis J.E. Genetic variation of iron-induced uroporphyria in mice. Biochem J. 291:1993;29-35.
21. d SWR mice. Biochem Pharmacol. 52:1996;1407-1413.
22. Casley W., Menzies J., Girard M., Larocque L., Mousseau N., Whitehouse L., Moon T. Differences in caffeine 3-demethylation activity among inbred mouse strains A comparison of hepatic Cyp1a2 gene expression between two inbred strains . Fundam Appl Toxicol. 40:1997;228-237.
23. Lambrecht R.W., Jacobs J.M. Sinclair PR and Sinclair JF, Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P450-mediated uroporphyrinogen oxidation. Biochem J. 269:1990;437-441.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
25. Sinclair P.R., Gorman N., Walton H.S., Sinclair J.F., Lee C.A., Rifkind A.B. Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by Ah receptor ligands in chicken liver and kidney. Drug Metab Dispos. 25:1997;779-783.
26. Torrance J.D., Bothwell T.H. A simple technique for measuring storage iron concentrations in formalinised liver samples. S Afr J Med Sci. 33:1968;9-11.
27. 3-450 genes. Dev Biol. 112:1985;177-184.
28. Smith A.G., Clothier B., Robinson S., Scullion M.J., Carthew P., Edwards R., Luo J., Lim C.K., Toledano M. Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene A hepatic oxidative mechanism . Mol Pharmacol. 53:1998;52-61.
29. Oinonen T., Lindros K.O. Zonation of hepatic cytochrome P-450 expression and regulation. Biochem J. 329:1998;17-35.
30. Siersema P.D., Cleton-Soeteman M.I., de Bruijn W.C., ten Kate F.J.W., van Eijk H.G., Wilson J.H.P. Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice A time-course study . Cell Tissue Res. 274:1993;405-412.
31. Urquhart A.J., Elder G.H., Roberts A.G., Lambrecht R.W., Sinclair P.R., Bement W.J., Gorman N., Sinclair J.F. Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolevulinic acid Biochem J. 253:1988;357-362.
32. Smith A.G., Latour I., Akhtar R.A., Robinson S., Clothier B., Festing M.F.W. Comparison of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with Ahr-genotype and hepatic CYP1A isoforms in iron loaded C57BL/6 X DBA/2 F2 mice. Toxicol Sci. 42:1998;381.
33. Jacobs J.M., Sinclair P.R., Bement W.J., Lambrecht R.W., Sinclair J.F., Goldstein J.A. Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P450. Biochem J. 258:1989;247-253.
34. Sinclair P.R., Jacobs J.M., Deam S.M., Lambrecht R.W., Sinclair J.F., Elder G.H. Relationship between lucigenin-enhanced chemiluminescence and uroporphyrinogen oxidation in mouse and chick embryo liver microsomes. Biochem Pharmacol. 39:1990;1828-1830.
35. Smith A.G., Clothier B., Francis J.E., Gibbs A.H., De Matteis F., Hider R.C. Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice. Blood. 89:1997;1045-1051.
36. Goldstein J.A., Linko P., Bergman H. Induction of porphyria in the rat by chronic versus acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol. 31:1982;1607-1613.
37. Koss G., Seubert S., Seidel J., Koransky W., Ippen H. Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment. Arch Toxicol. 52:1983;13-22.
38. Smith A.G., Francis J.E., Kay S.J.E., Greig J.B., Stewart F.P. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism. Biochem J. 238:1986;871-878.
39. Smith A.G., De Matteis F. Oxidative injury mediated by the hepatic cytochrome P450 system in conjunction with cellular iron. Effects on the pathway of haem biosynthesis. Xenobiotica. 20:1990;865-877.